Samalizumab
Product Specifications
CAS Number
1073059-33-2
Target
Immunology/Inflammation related
Related Pathways
Immunology/Inflammation
Purity
0.9564
Bioactivity
Samalizumab (ALXN 6000) is a humanized anti-CD200 monoclonal antibody that specifically targets the CD200 immunoregulatory cell surface protein, a member of the immunoglobulin superfamily which functions to dampen excessive immune responses and maintain self-tolerance, thereby establishing Samalizumab as an effective immune checkpoint inhibitor currently under investigation for the treatment of myeloma and B-cell chronic lymphocytic leukemia (CLL) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
37262124 3x 1.0µg DNA
POU3F3 CRISPRa sgRNA lentivector (set of three targets)(Mouse)
Sign In for Pricing
View Details 
orb1948210-01 48 Tests
Human Glycogen Synthase 2, Liver (GYS2) ELISA Kit
Sign In for Pricing
View Details orb1948210-02 96 Tests
Human Glycogen Synthase 2, Liver (GYS2) ELISA Kit
Sign In for Pricing
View Details 
